High levels of interferon-response gene signatures are associated with de novo and acquired resistance to CDK4/6 inhibitors in ER+ breast cancer Meeting Abstract


Authors: De Angelis, C.; Fu, X.; Cataldo, M. L.; Nardone, A.; Jansen, V. M.; Veeraraghavan, J.; Nanda, S.; Qin, L.; Sethunath, V.; Pereira, R.; Benelli, M.; Migliaccio, I.; Malorni, L.; Donaldson, J.; Selenica, P.; Brown, D. N.; Weigelt, B.; Reis-Filho, J. S.; Park, B. H.; Hurvitz, S. A.; Slamon, D. J.; Rimawi, M. F.; Jeselsohn, R.; Osborne, K.; Schiff, R.
Abstract Title: High levels of interferon-response gene signatures are associated with de novo and acquired resistance to CDK4/6 inhibitors in ER+ breast cancer
Meeting Title: 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 80
Issue: 4 Suppl.
Meeting Dates: 2019 Dec 10-14
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2020-02-01
Language: English
ACCESSION: WOS:000527012500032
DOI: 10.1158/1538-7445.Sabcs19-gs2-01
PROVIDER: wos
Notes: Meeting Abstract: GS2-01 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Britta Weigelt
    632 Weigelt
  2. Pier Selenica
    189 Selenica
  3. David Norman Brown
    91 Brown